Myopia Treatment Market Scope And Analysis

Report Code : TIPRE00016387
Category : Pharmaceuticals

Status : Published
No. of Pages : 206

Buy Now

Myopia Treatment Market Analysis, Size, and Growth (2024-2031)

Buy Now

Myopia Treatment Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 10,276.67 Million
Market Size by 2030	US$ 19,571.85 Million
Global CAGR (2022 - 2030)	8.39%
Historical Data	2020-2021
Forecast period	2022-2030
Segments Covered	By Type High Myopia Degenerative Myopia Progressive Myopia By Treatment Low-Dose Atropine Eye Drops Contact Lenses Ortho-K Refractive Surgery By Age Group Adult Myopia and Childhood Myopia By End User Hospitals and Clinics Specialty Clinics Refractive Surgery Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Alcon Haag Streit Holding Metall Zug Ziemer Group NIDEK CO LTD 2EyesVision Carl Zeiss AG CooperVision Topcon Healthcare Inc Bausch Health

Myopia Treatment Market News and Recent Developments

The myopia treatment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the myopia treatment market are listed below:

Eyenovia, Inc., a commercial-stage, ophthalmic company, announced that it has re-acquired the rights to MicroPine in the U.S. and Canada. MicroPine, an investigational eight microliter ophthalmic spray of atropine delivered by Eyenovia’s proprietary Optejet device, is being evaluated as a potential treatment for pediatric progressive myopia which is characterized by elongation of the sclera/retina. (Source: Eyenovia, Inc., Press Release, January 2024)
NIDEK CO LTD launched the NP-1/NP-1C Preloaded IOL Injection System. The NP-1/NP-1C is a fully preloaded injection system with an aspheric hydrophobic soft acrylic lens designed for smoother, safer, and secure IOL implantation. This newly developed injector is designed for smooth, controlled delivery. The NP-1/NP-1C allows quick and easy operation using a simple two-step process involving, filling the viscoelastic material and pressing the plunger. (Source: NIDEK CO LTD, Press Release, October 2023)

Myopia Treatment Market Report Coverage and Deliverables

The “Myopia Treatment Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

Myopia treatment market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Myopia treatment market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Myopia treatment market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Myopia treatment market
Detailed company profiles